Location: Boston, MA
CIK: 0001816307 · Show all filings
Period: Q4 2020 (Next →)
Filing Date: Feb 16, 2021
Total Value: $172M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VCEL | VERICEL CORP | 281,346 | $8.688M | 5.0% | $23.80 | 0.0% | COM | 92346J108 |
| — | BIOGEN INC | 30,000 | $7.346M | 4.3% | — | — | Call | 09062X903 |
| — | INTRA CELLULAR THERAPIES INC | 200,000 | $6.36M | 3.7% | $31.80 | — | COM | 46116X101 |
| DCTH | DELCATH SYS INC | 351,616 | $6.301M | 3.7% | $13.70 | 0.0% | COM NEW | 24661P807 |
| INSM | INSMED INC | 175,000 | $5.826M | 3.4% | $36.53 | 0.0% | COM PAR $.01 | 457669307 |
| — | AMRYT PHARMA PLC | 402,556 | $5.7M | 3.3% | $14.16 | — | SPONSORED ADS | 03217L106 |
| — | DICERNA PHARMACEUTICALS INC | 227,388 | $5.009M | 2.9% | $22.03 | — | COM | 253031108 |
| ARVN | ARVINAS INC | 55,000 | $4.671M | 2.7% | $34.48 | 0.0% | COM | 04335A105 |
| LRMR | LARIMAR THERAPEUTICS INC | 217,203 | $4.65M | 2.7% | $20.04 | 0.0% | COM | 517125100 |
| IMVT | IMMUNOVANT INC | 100,000 | $4.619M | 2.7% | $46.23 | 0.0% | COM | 45258J102 |
| — | MIRATI THERAPEUTICS INC | 20,000 | $4.393M | 2.6% | $219.65 | — | COM | 60468T105 |
| — | CURIS INC | 530,000 | $4.341M | 2.5% | $8.19 | — | COM NEW | 231269200 |
| HALO | HALOZYME THERAPEUTICS INC | 100,000 | $4.271M | 2.5% | $35.95 | 0.0% | COM | 40637H109 |
| — | TCR2 THERAPEUTICS INC | 136,000 | $4.206M | 2.4% | $30.93 | — | COM | 87808K106 |
| — | SUTRO BIOPHARMA INC | 185,000 | $4.016M | 2.3% | $21.71 | — | COM | 869367102 |
| — | IMMUNOGEN INC | 600,000 | $3.87M | 2.2% | $6.45 | — | COM | 45253H101 |
| — | ESSA PHARMA INC | 322,917 | $3.852M | 2.2% | $11.93 | — | COM NEW | 29668H708 |
| — | CELLECTAR BIOSCIENCES INC | 1,772,848 | $3.688M | 2.1% | $2.08 | — | COM PAR | 15117F500 |
| — | CHEMOCENTRYX INC | 53,766 | $3.329M | 1.9% | $61.92 | — | COM | 16383L106 |
| KURA | KURA ONCOLOGY INC | 90,000 | $2.939M | 1.7% | $35.14 | 0.0% | COM | 50127T109 |
| ASND | ASCENDIS PHARMA A/S | 17,556 | $2.928M | 1.7% | $166.78 | — | SPONSORED ADR | 04351P101 |
| — | JOUNCE THERAPEUTICS INC | 406,665 | $2.847M | 1.7% | $7.00 | — | COM | 481116101 |
| — | EVOGENE LTD | 600,000 | $2.82M | 1.6% | $4.70 | — | SHS | M4119S104 |
| COGT | COGENT BIOSCIENCES INC | 235,066 | $2.64M | 1.5% | $10.99 | 0.0% | COM | 19240Q201 |
| MLTX | HELIX ACQUISITION CORP | 215,071 | $2.445M | 1.4% | $11.37 | — | COM CL A | G4444C102 |
| GH | GUARDANT HEALTH INC | 18,825 | $2.426M | 1.4% | $115.06 | 0.0% | COM | 40131M109 |
| — | VERASTEM INC | 1,135,753 | $2.419M | 1.4% | $2.13 | — | COM | 92337C104 |
| — | AFFIMED N V | 400,000 | $2.328M | 1.4% | $5.82 | — | COM | N01045108 |
| — | RENALYTIX AI PLC | 141,253 | $2.26M | 1.3% | $16.00 | — | ADS | 75973T101 |
| — | DECIPHERA PHARMACEUTICALS IN | 38,620 | $2.204M | 1.3% | $57.07 | — | COM | 24344T101 |
| — | HORIZON THERAPEUTICS PUB L | 30,000 | $2.195M | 1.3% | $73.17 | — | SHS | G46188101 |
| — | SIERRA ONCOLOGY INC | 135,000 | $2.164M | 1.3% | $16.03 | — | COM NEW | 82640U404 |
| — | TURNING POINT THERAPEUTICS I | 16,131 | $1.966M | 1.1% | $121.88 | — | COM | 90041T108 |
| — | ADAMAS PHARMACEUTICALS INC | 440,955 | $1.909M | 1.1% | $4.33 | — | COM | 00548A106 |
| CGEN | COMPUGEN LTD | 150,550 | $1.823M | 1.1% | $13.79 | 0.0% | ORD | M25722105 |
| — | MORPHIC HLDG INC | 51,433 | $1.726M | 1.0% | $33.56 | — | COM | 61775R105 |
| — | OTONOMY INC | 263,951 | $1.708M | 1.0% | $6.47 | — | COM | 68906L105 |
| — | TRILLIUM THERAPEUTICS INC | 110,000 | $1.618M | 0.9% | $14.71 | — | COM NEW | 89620X506 |
| — | ARENA PHARMACEUTICALS INC | 20,000 | $1.537M | 0.9% | $76.85 | — | COM NEW | 040047607 |
| — | ZYMEWORKS INC | 30,834 | $1.457M | 0.8% | $47.25 | — | COM | 98985W102 |
| — | NEXTCURE INC | 130,000 | $1.417M | 0.8% | $10.90 | — | COM | 65343E108 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 16,500 | $1.414M | 0.8% | $85.70 | — | COM | G11196105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 80,282 | $1.407M | 0.8% | $18.00 | 0.0% | COM NEW | 15117B202 |
| — | SEAGEN INC | 7,509 | $1.315M | 0.8% | $175.12 | — | COM | 81181C104 |
| SRRK | SCHOLAR ROCK HLDG CORP | 25,000 | $1.213M | 0.7% | $36.31 | 0.0% | COM | 80706P103 |
| — | SURFACE ONCOLOGY INC | 130,000 | $1.201M | 0.7% | $9.24 | — | COM | 86877M209 |
| VRTX | VERTEX PHARMACEUTICALS INC | 5,000 | $1.182M | 0.7% | $229.44 | 0.0% | COM | 92532F100 |
| — | 89BIO INC | 44,007 | $1.072M | 0.6% | $24.36 | — | COM | 282559103 |
| — | KADMON HLDGS INC | 241,756 | $1.003M | 0.6% | $4.15 | — | COM | 48283N106 |
| MREO | MEREO BIOPHARMA GROUP PLC | 280,000 | $1.002M | 0.6% | $3.58 | — | ADS | 589492107 |
| NKTX | NKARTA INC | 15,000 | $922K | 0.5% | $41.53 | 0.0% | COM | 65487U108 |
| — | AKERO THERAPEUTICS INC | 35,179 | $908K | 0.5% | $25.81 | — | COM | 00973Y108 |
| — | IVERIC BIO INC | 130,043 | $899K | 0.5% | $6.91 | — | COM | 46583P102 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 110,000 | $820K | 0.5% | $5.16 | 0.0% | COM | 09058V103 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 5,364 | $814K | 0.5% | $131.23 | 0.0% | COM | 91307C102 |
| — | ALEXION PHARMACEUTICALS INC | 5,000 | $781K | 0.5% | $156.20 | — | COM | 015351109 |
| ARDX | ARDELYX INC | 120,000 | $776K | 0.5% | $5.93 | 0.0% | COM | 039697107 |
| — | CALITHERA BIOSCIENCES INC | 150,000 | $737K | 0.4% | — | — | Call | 13089P901 |
| BIIB | BIOGEN INC | 3,000 | $735K | 0.4% | $259.08 | 0.0% | COM | 09062X103 |
| — | CONSTELLATION PHARMCETICLS I | 25,200 | $726K | 0.4% | $28.81 | — | COM | 210373106 |
| ATNM | ACTINIUM PHARMACEUTICALS INC | 90,000 | $702K | 0.4% | $10.86 | 0.0% | COM | 00507W206 |
| — | KALA PHARMACEUTICALS INC | 102,198 | $693K | 0.4% | $6.78 | — | COM | 483119103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 30,000 | $667K | 0.4% | $20.74 | 0.0% | COM | 87164F105 |
| EXAS | EXACT SCIENCES CORP | 5,000 | $662K | 0.4% | $120.93 | 0.0% | COM | 30063P105 |
| — | SOLENO THERAPEUTICS INC | 322,798 | $623K | 0.4% | $1.93 | — | COM NEW | 834203200 |
| — | LEAP THERAPEUTICS INC | 275,000 | $619K | 0.4% | $2.25 | — | COM | 52187K101 |
| — | SERES THERAPEUTICS INC | 25,000 | $613K | 0.4% | $24.52 | — | COM | 81750R102 |
| — | GAMIDA CELL LTD | 70,852 | $594K | 0.3% | $8.38 | — | SHS | M47364100 |
| — | VYNE THERAPEUTICS INC | 349,624 | $552K | 0.3% | $1.58 | — | COM NEW | 92941V100 |
| RCKT | ROCKET PHARMACEUTICALS INC | 10,000 | $548K | 0.3% | $36.45 | 0.0% | COM | 77313F106 |
| — | THERAPEUTICS ACQUISITION COR | 39,009 | $543K | 0.3% | $13.92 | — | COM CL A | 88339T103 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 10,000 | $519K | 0.3% | $45.11 | 0.0% | COM | 98943L107 |
| MDNAF | MEDICENNA THERAPEUTICS CORP | 107,536 | $503K | 0.3% | $4.03 | 0.0% | COM | 58490H107 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 10,000 | $464K | 0.3% | $39.70 | 0.0% | COM | 462260100 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 20,910 | $422K | 0.2% | $21.52 | 0.0% | COM | 74366E102 |
| — | APTINYX INC | 107,536 | $372K | 0.2% | $3.46 | — | COM | 03836N103 |
| — | MERSANA THERAPEUTICS INC | 10,763 | $286K | 0.2% | $26.57 | — | COM | 59045L106 |
| — | COMPUGEN LTD | 20,000 | $242K | 0.1% | — | — | Call | M25722905 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 8,505 | $239K | 0.1% | $24.49 | 0.0% | COM | 03969K108 |
| FULC | FULCRUM THERAPEUTICS INC | 16,209 | $190K | 0.1% | $11.31 | 0.0% | COM | 359616109 |
| — | BIOMX INC | 13,759 | $88,000 | 0.1% | $6.40 | — | COM | 09090D103 |
| — | CALITHERA BIOSCIENCES INC | 15,000 | $74,000 | 0.0% | $4.93 | — | COM | 13089P101 |
| — | CHARDAN HEALTHCR ACQSTN 2 CO | 98,756 | $49,000 | 0.0% | $0.50 | — | *W EXP 03/05/202 | 15957T115 |
| — | BIONANO GENOMICS INC | 10,000 | $21,000 | 0.0% | $2.10 | — | *W EXP 08/21/202 | 09075F115 |